ReWalk Announces Cigna as First Private U.S. Insurer to Adopt National Policy Change for Coverage of Personal Exoskeleton Devices
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel,
"This is a major milestone for healthcare beneficiaries in
This policy update marks the latest national decision in the
"ReWalk has prioritized interacting directly with payors and educating them regarding the benefits of exoskeletons use, and Cigna's decision comes after providing them the most recent evidence. We anticipate that other payors will follow Cigna's leadership in providing the latest and most current technologies for their members," Jasinski added.
About ReWalk Robotics Ltd.
ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke. The Company's mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the United States, Israel and Germany. For more information on the ReWalk systems, please visit www.rewalk.com.
ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel and the
Forward-Looking Statements
In addition to historical information, this press release contains forward-looking statements within the meaning of the
View original content to download multimedia:http://www.prnewswire.com/news-releases/rewalk-announces-cigna-as-first-private-us-insurer-to-adopt-national-policy-change-for-coverage-of-personal-exoskeleton-devices-300794768.html
SOURCE
Brighthouse Financial Unveils a Smart New Way to Plan for Long-Term Care Expenses
Arson trial reveals source of 2016 Prospect explosion
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News